On August 29, 2022, AXIM Biotechnologies, Inc. closed the transaction. The Company sold the securities in reliance upon an exemption from registration contained in Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 USD | +5.26% | -15.25% | -47.37% |
16/04 | AXIM Biotechnologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
15/03 | AXIM Biotechnologies, Inc. announced that it has received $0.814555 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-47.37% | 2.65M | |
+33.68% | 49.46B | |
+1.56% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.69% | 26.61B | |
-21.04% | 18.64B | |
+7.39% | 13.16B | |
+28.64% | 12.55B | |
+23.85% | 12.1B |
- Stock Market
- Equities
- AXIM Stock
- News AXIM Biotechnologies, Inc.
- AXIM Biotechnologies, Inc. announced that it has received $0.1 million in funding